60 Degrees Pharmaceuticals, Inc. (SXTP) Ownership
SXTP ownership summary
as of October 18, 2026- Institutions
- 17.1% of shares outstanding
- Insiders
- 19.39% of shares outstanding
- Shares outstanding
- 3.5M
- Float
- 2.4M shares available to trade
- Short interest
- 3.82% 133K shares short
- Days to cover
- 1.73 short interest down 38.3% vs prior month
- Institutions 17.11%
- Insiders 19.39%
- Other investors 63.50%
SXTP top institutional holders
13 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Kathmere Capital Management, LLC | 7.54% | 265K | $226,660 | +120,417 (+83.2%) | June 30, 2026 |
| 2 | Citadel Advisors Llc | 0.64% | 22K | $19,120 | +22,362 (0.0%) | June 30, 2026 |
| 3 | XTX Topco Ltd | 0.50% | 18K | $15,081 | +17,639 (0.0%) | June 30, 2026 |
| 4 | Kovack Advisors Inc | 0.43% | 15K | $12,825 | +15,000 (0.0%) | June 30, 2026 |
| 5 | Geode Capital Management, LLC | 0.41% | 15K | $12,441 | −1,744 (−10.7%) | June 30, 2026 |
| 6 | UBS Group AG | 0.39% | 14K | $11,621 | −17,818 (−56.7%) | June 30, 2026 |
| 7 | Barclays PLC | 0.03% | 1,052 | $899 | −804 (−43.3%) | June 30, 2026 |
| 8 | Advisor Group Holdings, Inc. | <0.01% | 25 | $21 | — | June 30, 2026 |
| 9 | Tower Research Capital LLC | 0.00% | — | — | −1,684 (−100.0%) | March 31, 2026 |
| 10 | Goss Wealth Management LLC | 0.00% | — | — | −50 (−100.0%) | June 30, 2026 |
| 11 | TWIN PEAKS WEALTH ADVISORS LLC | 0.00% | — | — | −8 (−100.0%) | June 30, 2026 |
| 12 | Citigroup Inc | 0.00% | — | — | −1 (−100.0%) | June 30, 2026 |
| 13 | Bank of America Corp | 0.00% | — | — | −8 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 13, 4 holders added 175K shares and 8 cut 22K.
SXTP top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.41% | 14K | $12,295 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
SXTP insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-15 | Geoffrey S Dow | Buy | $3.20 | 2,417 | $7,734 |
| 2025-12-11 | Geoffrey S Dow | Buy | $3.68 | 903 | $3,323 |
| 2025-12-10 | Geoffrey S Dow | Buy | $3.80 | 2,337 | $8,881 |
| 2025-06-03 | Cheryl Xu | Buy | $11.52 | 1,250 | $14,400 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
SXTP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns SXTP
Institutional investors own 17.1% of 60 Degrees Pharmaceuticals's shares and insiders 19.39%. The largest holder is Kathmere Capital Management, LLC with 7.54% of the shares (265K), as of June 30, 2026. Among the top 13 institutions, 4 added shares and 8 reduced their stake in the latest filings. Short interest is 3.82% of the float, or 1.73 days of average trading volume. The share count rose 4,706.2% since 2021.
Related: SXTP analyst forecast, SXTP key metrics. See the SXTP stock overview for the latest quote and news.
SXTP ownership FAQ
Who owns the most 60 Degrees Pharmaceuticals stock?
The largest shareholders of 60 Degrees Pharmaceuticals are Kathmere Capital Management, LLC (7.54%), Citadel Advisors Llc (0.64%), XTX Topco Ltd (0.50%), Kovack Advisors Inc (0.43%), Geode Capital Management, LLC (0.41%).
What percentage of 60 Degrees Pharmaceuticals is owned by institutions?
Institutions hold 17.1% of 60 Degrees Pharmaceuticals's shares outstanding; insiders hold 19.39%.
Which funds own 60 Degrees Pharmaceuticals?
The largest fund holders of 60 Degrees Pharmaceuticals are Fidelity Extended Market Index (0.41%).
What is 60 Degrees Pharmaceuticals's short interest?
133K shares of 60 Degrees Pharmaceuticals were sold short, 3.82% of the float; at the average daily volume it would take 1.73 days to cover.
Are insiders buying or selling 60 Degrees Pharmaceuticals?
Of the latest 4 reported insider transactions in 60 Degrees Pharmaceuticals (since June 3, 2025), 4 were purchases and 0 were sales.
How many shares of 60 Degrees Pharmaceuticals are outstanding?
60 Degrees Pharmaceuticals has 3.5M shares outstanding, of which 2.4M are in the public float.